![]() |
|
|
,2




* Department of Clinical Nutrition, University of Kuopio and
Kuopio University Hospital, Kuopio; ** Danisco Innovation, Enteromix Research, Kantvik, Finland; and
Drug Research Unit, and 
Biomarker Laboratory, the National Public Health Institute, Helsinki, Finland
2 To whom correspondence should be addressed. E-mail: Ursula.Schwab{at}uku.fi
ABSTRACT
Betaine, i.e., trimethylglycine, is linked to homocysteine metabolism. A 3-mo daily betaine supplementation decreased even normal plasma total homocysteine (tHcy) concentrations in humans. The pharmacokinetic characteristics and metabolism of betaine in humans have not been investigated in detail. The aim of this study was to assess the pharmacokinetics of orally administered betaine and its acute effect on plasma tHcy concentrations. Healthy volunteers (n = 10; 3 men, 7 women) with normal body weight (mean ± SD, 69.5 ± 17.0 kg), 40.8 ± 12.4 y old, participated in the study. The betaine doses were 1, 3, and 6 g. The doses were mixed with 150 mL of orange juice and ingested after a 12-h overnight fast by each volunteer according to a randomized double-blind crossover design. Blood samples were drawn for 24 h and a 24-h urine collection was performed. Orally administered betaine had an immediate and dose-dependent effect on serum betaine concentration. Single doses of 3 and 6 g lowered plasma tHcy concentrations (P = 0.019 and P < 0.001, respectively), unlike the 1-g dose. After the highest dose, the concentrations remained low during the 24 h of monitoring. The change in plasma tHcy concentration was linearly associated with betaine dose (P = 0.006) and serum betaine concentration (R2 = 0.17, P = 0.025). The absorption and elimination of betaine were dose dependent. The urinary excretion of betaine seemed to increase with an increasing betaine dose, although a very small proportion of ingested betaine was excreted via urine. In conclusion, a single dose of orally administered betaine had an acute and dose-dependent effect on serum betaine concentration and resulted in lowered plasma tHcy concentrations within 2 h in healthy subjects.
KEY WORDS: Betaine cysteine dimethylglycine homocysteine human
This article has been cited by other articles:
![]() |
W. Atkinson, J. Elmslie, M. Lever, S. T Chambers, and P. M George Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects Am. J. Clinical Nutrition, March 1, 2008; 87(3): 577 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Holm, S. Hustad, P. M. Ueland, S. E. Vollset, T. Grotmol, and J. Schneede Modulation of the Homocysteine-Betaine Relationship by Methylenetetrahydrofolate Reductase 677 C->T Genotypes and B-Vitamin Status in a Large-Scale Epidemiological Study J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1535 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Collinsova, J. Strakova, J. Jiracek, and T. A. Garrow Inhibition of Betaine-Homocysteine S-Methyltransferase Causes Hyperhomocysteinemia in Mice J. Nutr., June 1, 2006; 136(6): 1493 - 1497. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Oda Functions of Sulfur-Containing Amino Acids in Lipid Metabolism J. Nutr., June 1, 2006; 136(6): 1666S - 1669S. [Abstract] [Full Text] [PDF] |
||||